Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines

Clicks: 3
ID: 291019
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #402 of 532 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 532 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
fective clinical management of STDs represent an important combined strategy necessary to improve reproductive and sexual health and to improve HIV prevention efforts. This is especially relevant to women, adolescents, and infants, because untreated infections frequently result in severe, long-term complications, including facilitation of HIV infection, tubal infertility, adverse pregnancy outcomes, and cancer. For >20 years, the publication of national guidelines by the Centers for Disease Control and Prevention
Reference Key
openalex_W2162847806 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kimberly Workowski, Simeon M. Berman
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2007
DOI
10.1086/511430
URL
https://academic.oup.com/cid/article-pdf/44/Supplement_3/S73/20908079/44-Supplement_3-S73.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.